Top

Endocrine

Published in:

01-08-2020 | Original Article

Global burden of noncommunicable disease attributable to high body mass index in 195 countries and territories, 1990–2017

Authors: Xiling Lin, Yufeng Xu, Jingya Xu, Xiaowen Pan, Xiaoxiao Song, Lizhen Shan, Yiming Zhao, Peng-Fei Shan

Published in: Endocrine | Issue 2/2020

Abstract

Purpose

The increasing burden of noncommunicable diseases (NCDs) attributable to high body mass index (BMI) represents both a threat and an opportunity for intervention. Estimates of the global latest trend of high BMI-related NCDs and its association with socioeconomic status can facilitate strategic intervention and inform further research.

Methods

This global burden of disease study extracted global, regional, and national data on death and disability-adjusted life years (DALYs) attributable to high BMI-related NCDs from the GBD Study 2017. Secondary analyses were performed by year, age, sex, and specific causes of death and DALYs. The 2017 Socio-demographic Index (SDI) was used as an indicator of national socioeconomic status. The association between age-standardized death or DALYs rate and socioeconomic status were analyzed.

Results

Worldwide, 4.7 million deaths and 147.7 million DALYs of NCDs were related to high BMI in 2017, with a projection to 5.5 million deaths and 176.9 million DALYs in 2025. Globally, high BMI-related burden showed an increasing trend with males being more heavily impacted overall. The trend and magnitude of high BMI-related disease burden varied substantially in different geographical and socioeconomic regions. Specifically, the low-middle, middle, and high-middle SDI countries were associated with a higher burden. The leading three causes of DALYs attributable to high BMI in 2017 were ischemic heart diseases, stroke, and diabetes mellitus.

Conclusions

High BMI-related burden of NCDs is worsening, particularly in developing countries. Our findings may enhance public awareness of interventions to reduce the diseases burden caused by high BMI.

Available only for authorised users

M. Ng, T. Fleming, M. Robinson, B. Thomson, N. Graetz, C. Margono et al. Global, regional and national prevalence of overweight and obesity in children and adults 1980–2013: a systematic analysis. Lancet 384(9945), 766–781 (2014). https://doi.org/10.1016/S0140-6736(14)60460-8 CrossRefPubMedPubMedCentral

WHO expert consultation., Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363(9412), 157–163 (2004). https://doi.org/10.1016/S0140-6736(03)15268-3 CrossRef

S. Kent, J. Green, G. Reeves, V. Beral, A. Gray, S.A. Jebb et al. Hospital costs in relation to body-mass index in 1.1 million women in England: a prospective cohort study. Lancet Public Health 2(5), e214–e222 (2017). https://doi.org/10.1016/S2468-2667(17)30062-2 CrossRefPubMedPubMedCentral

D.T. Chu, N.T. Minh Nguyet, T.C. Dinh, N.V. Thai Lien, K.H. Nguyen, V.T. Nhu Ngoc et al. An update on physical health and economic consequences of overweight and obesity. Diabetes Metab. Syndr. Clin. Res. Rev 12(6), 1095–1100 (2018). https://doi.org/10.1016/j.dsx.2018.05.004 CrossRef

L. Yang, G.A. Colditz, Prevalence of overweight and obesity in the United States, 2007–2012. JAMA Intern. Med. 175(8), 1412–1413 (2015). https://doi.org/10.1001/jamainternmed.2015.2405 CrossRefPubMedPubMedCentral

Y.J. Mi, B. Zhang, H.J. Wang, J. Yan, W. Han, J. Zhao et al. Prevalence and secular trends in obesity among Chinese adults, 1991–2011. Am. J. Prev. Med. 49(5), 661–669 (2015). https://doi.org/10.1016/j.amepre.2015.05.005 CrossRefPubMedPubMedCentral

A. Afshin, M.H. Forouzanfar, M.B. Reitsma, P. Sur, K. Estep, A. Lee et al. Health Effects of overweight and obesity in 195 countries over 25 years. N. Engl. J. Med. 377(1), 13–27 (2017). https://doi.org/10.1056/NEJMoa1614362 CrossRefPubMed

World Health Organization. Global Health Observatory (GHO) data.https://www.who.int/gho/ncd/risk_factors/overweight/en/. Accessed 1 June 2019

S.L. Marrero, D.E. Bloom, E.Y. Adashi, Noncommunicable diseases: A global health crisis in a new world order. JAMA 307(19), 2037–2038 (2012). https://doi.org/10.1001/jama.2012.3546 CrossRefPubMed

10.

Mohsen Naghavi, H.W, Rafael Lozano, Adrian Davis, Xiaofeng Liang, Maigeng Zhou, SteinEmil Vollset et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385(9963), 117–171 (2015). https://doi.org/10.1016/S0140-6736(14)61682-2 CrossRef

11.

World Health Organization. Global Action Plan for the Prevention and Control of NCDs 2013–2020 (2013). http://www.who.int/nmh/events/ncd_action_plan/en/. Accessed 1 June 2019

12.

J. Pearson-Stuttard, B. Zhou, V. Kontis, J. Bentham, M.J. Gunter, M. Ezzati, Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment. Lancet Diabetes Endocrinol 6(6), e6–e15 (2018). https://doi.org/10.1016/S2213-8587(18)30150-5 CrossRefPubMedPubMedCentral

13.

Y. Lu, K. Hajifathalian, M. Ezzati, M. Woodward, E.B. Rimm, G. Danaei et al. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: A pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet 383(9921), 970–983 (2014). https://doi.org/10.1016/S0140-6736(13)61836-X CrossRefPubMed

14.

D.K. Tobias, A. Pan, C.L. Jackson, E.J. O’Reilly, E.L. Ding, W.C. Willett et al. Body-Mass index and mortality among adults with incident type 2 diabetes. N. Engl. J. Med. 370(3), 233–244 (2014). https://doi.org/10.1056/NEJMoa1304501 CrossRefPubMedPubMedCentral

15.

J.H. Ryoo, S.K. Park, S. Ye, J.M. Choi, C.M. Oh, S.Y. Kim et al. Estimation of risk for diabetes according to the metabolically healthy status stratified by degree of obesity in Korean men. Endocrine 50(3), 650–658 (2015). https://doi.org/10.1007/s12020-015-0635-5 CrossRefPubMed

16.

D. Dicker, G. Nguyen, D. Abate, K.H. Abate, S.M. Abay, C. Abbafati et al. Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1684–1735 (2018). https://doi.org/10.1016/S0140-6736(18)31891-9 CrossRef

17.

H.H. Kyu, D. Abate, K.H. Abate, S.M. Abay, C. Abbafati, N. Abbasi et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392(10159), 1859–1922 (2018). https://doi.org/10.1016/S0140-6736(18)32335-3 CrossRef

18.

J.D. Stanaway, A. Afshin, E. Gakidou, S.S. Lim, D. Abate, K.H. Abate et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392(10159), 1923–1994 (2018). https://doi.org/10.1016/S0140-6736(18)32225-6 CrossRef

19.

Global Health Data Exchange. http://ghdx.healthdata.org/gbd-results-tool. Institute for Health Metrics and Evaluation (IHME). Accessed 1 June 2019

20.

S.L. James, D. Abate, K.H. Abate, S.M. Abay, C. Abbafati, N. Abbasi et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392(10159), 1789–1858 (2018). https://doi.org/10.1016/S0140-6736(18)32279-7 CrossRef

21.

D.N. Juurlink, M.M. Mamdani, D.S. Lee, A. Kopp, P.C. Austin, A. Laupacis et al. Rates of hyperkalemia after publication of the randomized aldactone evaluation study. N. Engl. J. Med. 351(6), 543–551 (2004). https://doi.org/10.1056/nejmoa040135 CrossRefPubMed

22.

K.J. Foreman, N. Marquez, A. Dolgert, K. Fukutaki, N. Fullman, M. McGaughey et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet 392(10159), 2052–2090 (2018). https://doi.org/10.1016/S0140-6736(18)31694-5 CrossRefPubMedPubMedCentral

23.

R.G. Kavasseri, K. Seetharaman, Day-ahead wind speed forecasting using f-ARIMA models. Renew. Energy 34(5), 1388–1393 (2009). https://doi.org/10.1016/j.renene.2008.09.006 CrossRef

24.

L. McLaren, Socioeconomic status and obesity. Epidemiol. Rev. 29(1), 29–48 (2007). https://doi.org/10.1093/epirev/mxm001 CrossRefPubMed

25.

G.A.V.V. Murphy, G. Asiki, K. Ekoru, R.N. Nsubuga, J. Nakiyingi-miiro, E.H. Young et al. Sociodemographic distribution of non-communicable disease risk factors in rural Uganda: a cross-sectional study. Int. J. Epidemiol. 42(6), 1740–1753 (2013). https://doi.org/10.1093/ije/dyt184 CrossRefPubMedPubMedCentral

26.

M. Elaine, Power determinants of healthy eating among low-income Canadians. Can. J. Public Heal 96, S20–S26 (2005). https://doi.org/10.17269/CJPH.96.1504 CrossRef

27.

J. Brug, Determinants of healthy eating: motivation, abilities and environmental opportunities. Fam. Pract 25, 50–55 (2009). https://doi.org/10.1093/fampra/cmn063 CrossRef

28.

R.A. Shaikh, M. Siahpush, G.K. Singh, M. Tibbits, Socioeconomic status, smoking, alcohol use, physical activity, and dietary behavior as determinants of obesity and body mass index in the United States: findings from the National Health Interview Survey. Int. J. MCH AIDS 4(1), 22–34 (2015)CrossRef

29.

A. Misra, L. Khurana, Obesity and the metabolic syndrome in developing countries. J. Clin. Endocrinol. Metab. 93(11), 9–30 (2008). https://doi.org/10.1210/jc.2008-1595 CrossRef

30.

B.M. Popkin, L.S. Adair, S.W. Ng, Global nutrition transition and the pandemic of obesity in developing countries. Nutr. Rev 70(1), 3–21 (2012). https://doi.org/10.1111/j.1753-4887.2011.00456.x CrossRefPubMedPubMedCentral

31.

A. Tchernof, A. Desmeules, C. Richard, P. Laberge, M. Daris, J. Mailloux et al. Ovarian hormone status and abdominal visceral adipose tissue metabolism. J. Clin. Endocrinol. Metab. 89(7), 3425–3430 (2004). https://doi.org/10.1210/jc.2003-031561 CrossRefPubMed

32.

B.H. Goodpaster, S. Krishnaswami, T.B. Harris, A. Katsiaras, S.B. Kritchevsky, E.M. Simonsick et al. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch. Intern. Med. 165(7), 777–783 (2005). https://doi.org/10.1001/archinte.165.7.777 CrossRefPubMed

33.

J.P. Després, Body fat distribution and risk of cardiovascular disease: An update. Circulation 126(10), 1301–1313 (2012). https://doi.org/10.1161/CIRCULATIONAHA.111.067264 CrossRefPubMed

34.

D.T. Duncan, K.Y. Wolin, M. Scharoun-Lee, E.L. Ding, E.T. Warner, G.G. Bennett, Does perception equal reality? Weight misperception in relation to weight-related attitudes and behaviors among overweight and obese US adults. Int. J. Behav. Nutr. Phys. Act 8, 1–9 (2011). https://doi.org/10.1186/1479-5868-8-20 CrossRef

35.

M. Cluskey, D. Grobe, College weight gain and behavior transitions: male and female differences. J. Am. Diet Assoc. 109(2), 325–329 (2009). https://doi.org/10.1016/j.jada.2008.10.045 CrossRefPubMed

36.

S. Lemieux, J.P. Despr, S. Moorjani, A. Nadeau, G. Th, D. Prud et al. Are gender differences in cardiovascular disease risk factors explained by the level of visceral adipose tissue? Diabetologia 37, 757–764 (1994)CrossRef

37.

World Health Organization. Noncommunicable diseases country profiles 2018 (2018). https://apps.who.int/iris/bitstream/handle/10665/274512/9789241514620-eng.pdf. Accessed 1 June 2019

38.

I.O.O. Ajayi, C. Adebamowo, H.O. Adami, S. Dalal, M.B. Diamond, F. Bajunirwe et al. Urban-rural and geographic differences in overweight and obesity in four sub-Saharan African adult populations: a multi-country cross-sectional study. BMC Public Health 16(1), 1–13 (2016). https://doi.org/10.1186/s12889-016-3789-z CrossRef

39.

N. Shapira, Women’s higher health risks in the obesogenic environment: a gender nutrition approach to metabolic dimorphism with predictive, preventive, and personalised medicine. EPMA J 4(1), 1 (2013). https://doi.org/10.1186/1878-5085-4-1 CrossRefPubMedPubMedCentral

40.

S.S. Khan, H. Ning, J.T. Wilkins, N. Allen, M. Carnethon, J.D. Berry et al. Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity. JAMA Cardiol 3(4), 280–287 (2018). https://doi.org/10.1001/jamacardio.2018.0022 CrossRefPubMedPubMedCentral

41.

P. Nordström, N.L. Pedersen, Y. Gustafson, K. Michaëlsson, A. Nordström, Risks of myocardial infarction, death, and diabetes in identical twin pairs with different body mass indexes. JAMA Intern. Med. 176(10), 1522–1529 (2016). https://doi.org/10.1001/jamainternmed.2016.4104 CrossRefPubMed

42.

G. Bray, I. Culbert, C. Champagne, M. Crow, L. Dawson, B. Eberhardt et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346(6), 393–403 (2002)CrossRef

43.

G. Li, P. Zhang, J. Wang, E.W. Gregg, W. Yang, Q. Gong et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 371(9626), 1783–1789 (2008). https://doi.org/10.1016/S0140-6736(08)60766-7 CrossRefPubMed

44.

L. Jiang, A. Johnson, K. Pratte, J. Beals, A. Bullock, S.M. Manson, Long-term outcomes of lifestyle intervention to prevent diabetes in American Indian and Alaska native communities: The special diabetes program for Indians diabetes prevention program. Diabetes Care 41(7), 1462–1470 (2018). https://doi.org/10.2337/dc17-2685 CrossRefPubMedPubMedCentral

45.

M. Arnold, N. Pandeya, G. Byrnes, A.G. Renehan, G.A. Stevens, M. Ezzati et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol. 16(1), 36–46 (2015). https://doi.org/10.1016/S1470-2045(14)71123-4 CrossRefPubMed

46.

U.P. Gujral, E. Vittinghoff, M. Mongraw-Chaffin, D. Vaidya, N.R. Kandula, M. Allison et al. Cardiometabolic abnormalities among normal-weight persons from five racial/ethnic groups in the United States: a cross-sectional analysis of two cohort studies. Ann. Intern. Med. 166(9), 628–636 (2017). https://doi.org/10.7326/M16-1895.Cardiometabolic CrossRefPubMedPubMedCentral

47.

S. Heymsfield, M. Russell, R.N. Pierson, J. Wang, J.C. Thornton, S. Burastero, Asians have lower body mass index (BMI) but higher percent body fat than do whites: comparisons of anthropometric measurements. Am. J. Clin. Nutr. 60(1), 23–28 (1994). https://doi.org/10.1093/ajcn/60.1.23 CrossRef

48.

L.T. Ho-Pham, T.Q. Lai, N.D. Nguyen, E. Barrett-Connor, T.V. Nguyen, Similarity in percent body fat between White and Vietnamese Women: implication for a Universal Definition of Obesity. Obesity 18(6), 1242–1246 (2010). https://doi.org/10.1038/oby.2010.19 CrossRefPubMed

Title: Global burden of noncommunicable disease attributable to high body mass index in 195 countries and territories, 1990–2017
Authors: Xiling Lin
Yufeng Xu
Jingya Xu
Xiaowen Pan
Xiaoxiao Song
Lizhen Shan
Yiming Zhao
Peng-Fei Shan
Publication date: 01-08-2020
Publisher: Springer US
Published in: Endocrine / Issue 2/2020
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-020-02352-y

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Global burden of noncommunicable disease attributable to high body mass index in 195 countries and territories, 1990–2017

Abstract

Purpose

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2020

Consideration on TMPRSS2 and the risk of COVID-19 infection in Cushing’s syndrome

Efficacy and safety of statin use in children and adolescents with familial hypercholesterolaemia: a systematic review and meta-analysis of randomized-controlled trials

Clinical outcomes and characteristics of P30L mutations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency

The efficacy of vitamin D combined with clomiphene citrate in ovulation induction in overweight women with polycystic ovary syndrome: a double blind, randomized clinical trial

Correction for hyperfunctioning radiation-induced stunning (CHRIS) in benign thyroid diseases

Post-transplant diabetes mellitus: incidence, predicting factors and outcomes

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page